title: Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes.
authors.forename: G
authors.initials: G
authors.lastname: Jerums
authors.forename: M E
authors.initials: ME
authors.lastname: Cooper
authors.forename: R E
authors.initials: RE
authors.lastname: Gilbert
authors.forename: R C
authors.initials: RC
authors.lastname: Atkins
mesh_terms: D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003928:Diabetic Nephropathies / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000517:prevention & control*; D000077405:Irbesartan; D007668:Kidney / Q000187:drug effects; D019808:Losartan / Q000008:administration & dosage*; D008297:Male; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D013777:Tetrazoles / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000804:Angiotensin II; D000077405:Irbesartan; D019808:Losartan